Dr. Belldegrun resides in Los Angeles with his wife Dr. Rebecka Belldegrun, President and CEO of Bellco Capital, and their four children.
"I am extremely excited to join Two River as its Chairman and look forward to leading the development and creation of our portfolio companies. With our therapeutic technologies in development, we have the potential to address several major unmet medical needs and a unique opportunity to change patients' lives," said Arie Belldegrun, MD, FACS.
"We are honored to have Dr. Belldegrun join us at Two River," said Peter Kash, co-founder of Two River. "Arie and I have a relationship that goes back many years. It is built on trust and mutual respect, and has culminated in this union. We look forward to the benefit of his strategic vision and guidance as we continue to grow and build our portfolio companies."
About Two River Group Holdings
Two River is biotechnology focused venture capital firm that creates
and manages development stage biotechnology companies to develop novel
human therapeutic technologies that target a broad range of therapeutic
areas, including oncology, cardiovascular disease, ophthalmology and
metabolic disorders. Two River's goal is to create a limited number of high
quality companies, each having a pipeline of clinical and preclinical
compounds that address a common therapeutic area and a management team with
relevant industry experience. To achieve this goal, the Two River team
conducts rigorous clinical, legal and financial due diligence on hundreds
of technologies each year, choosing only a select few to acquire for
|SOURCE Two River Group Holdings, LLC|
Copyright©2008 PR Newswire.
All rights reserved